The global surgical instrument market size was USD 18.98 Billion in 2022 and is expected to register a revenue CAGR of 8.0% during the forecast period.
- The surgical sutures segment is expected to register a rapid revenue growth rate during the forecast period.
- The electrosurgical devices segment is expected to register a moderate revenue growth rate during the forecast period.
- The neurosurgery segment is expected to register a rapid revenue growth rate during the forecast period.
- The cardiovascular segment is expected to register a steady revenue growth rate during the forecast period.
- The disposable segment is expected to register a steady revenue growth rate during the forecast period.
- The reusable segment is expected to register a steady revenue growth rate during the forecast period.
- The North America market accounted for a significant revenue share in 2022.
- The Europe market accounted for a significant revenue share in 2022.
Request a Sample@ https://www.qyresearchmedical.com/sample/119576
Report Scope of the Surgical Instrument Market:
|The market size value in 2022||USD 18.98 Billion|
|CAGR (2023 – 2032)||8.0%|
|CAGR (2021 – 2030)||USD 38.13 Billion|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
Increasing prevalence of different chronic diseases such as cardiovascular diseases, cancer, and neurological disorders, and rising number of accidents and trauma emergencies, are key factors driving market revenue growth. Surgical instruments are portable tools used by physicians and other health care professionals to change, hold, clamp, cut, retract, dilate biological tissue, or provide access for observing it. In addition, these tools are used to get access to soft tissue, dissect lesions, or remove bone. Some of the most commonly used surgical instruments are scalpels, scissors, forceps, clamps, and retractors. These instruments come in a variety of sizes and are often constructed of carbon steel, aluminum, stainless steel, plastic, and polymers.
In the field of surgical instruments, there has been a significant growth in cost-effective medical equipment and high-performance components for greater productivity and efficiency during the past few years. OEMs have used medical-grade plastics as a realistic, inventive alternative to traditional metal equivalent to provide easier processability with equivalent or enhanced functionality. Modern surgical equipment needs plastics with superior strength, stiffness, and mechanical performance to compete with and outperform conventional metals. Plastics provide both disposable and reusable surgical tools with exceptionally high tensile and flexural strength, allowing for superior stiffness and mechanical stress resistance. These high-performance medical-grade resins retain their toughness and impact resistance after severe surgical operations, lengthy chemical exposure, and high-temperature steam sterilizing techniques. Medical-grade plastics are rapidly becoming the material of choice for a variety of surgical instruments. Moreover, use of plastic in surgical instruments offers various advantages including reduced cost, enhanced ergonomics, and enhanced functionality. Polymers provide remarkable sterilization resilience as well as chemical resistance, allowing reusable surgical tool plastics to withstand over a thousand cycles of steam sterilization or autoclaving without suffering substantial performance degradation.
The CDC Healthcare-Associated Infection (HAI) Prevalence Survey found that inpatient surgeries caused about 110,800 Surgical Site Infections (SSIs). Based on HAI data results for 2020 that were published in NHSN’s HAI Progress Report, SSI Standardized Infection Ratio (SIR) for all NHSN operative procedure categories decreased by about 5% in 2020 compared to the previous year. In 2020, it was said that SIR related to Surgical Care Improvement Project (SCIP) NHSN operative procedure categories had dropped by about 5% compared to the previous year. In both public and private hospitals, total frequency of surgical site infections was 9.9, which were found in 13.4% of public hospitals and 6.5% of private hospitals.
Competitive landscape of global surgical instruments market is fragmented with many key companies operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand their respective product portfolios and gain a robust footing in the global market. Major companies in the market include Smith+Nephew, Zimmer Biomet, B. Braun Melsungen AG, Stryker, Dextera Surgical Inc., Aspen Surgical., Alcon, BD, Medtronic, and Boston Scientific Corporation.
Surgical Instrument Market Segmentations:
By Product Type Outlook
- Surgical Sutures & Staplers
- Handheld Surgical Devices
- Forces & Spatulas
- Auxiliary Instrument
- Cutter Instrument
- Electrosurgical Devices
By Application Outlook
- Obstetrics & Gynecology
- Wound Closure
- Plastic & Reconstructive Surgery
By Category Outlook
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Buy quantitative research Report at discounted price – USD 1599 https://www.qyresearchmedical.com/report/checkout/119576/
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: